Mindray has moved fast in the premium ultrasound market, and the Resona series is the proof. A decade ago Mindray was largely a mid-tier and budget option. Today the Resona R9 competes head-to-head with systems from GE, Siemens, and Philips at a price that gives buyers real room in the budget. That combination of premium imaging and competitive pricing is why we are seeing more Resona purchases from practices that previously went straight to the legacy American and European brands.
The Resona 7 sits below the R9 and covers most of the same clinical applications at a lower price. The ME8 is a compact shared-service system for practices needing strong performance in a cart that is easier to move between rooms. The TEX20 targets elastography-heavy applications in hepatology and musculoskeletal imaging.
Mindray systems are almost always priced below competing legacy-brand models at equivalent clinical capability, which means the transaction amounts are often in a range where application-only financing is sufficient. The Resona R9 typically prices between $100,000 and $180,000. The Resona 7 generally runs $70,000 to $130,000. Both are comfortably within the application-only threshold for most transactions.